Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13

Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13

Abstract Fungal infections caused by Candida spp. represent an emerging problem during treatment of immunocompromised patients and those hospitalized with serious principal diseases. The ever-growing number of fungal strains exhibiting drug resistance necessitates the development of novel antimicrob...

Full description

Bibliographic Details
Main Authors:	Katarzyna Niemirowicz, Bonita Durnaś, Grażyna Tokajuk, Ewelina Piktel, Grzegorz Michalak, Xiaobo Gu, Alina Kułakowska, Paul B. Savage, Robert Bucki
Format:	Article
Language:	English
Published:	Nature Portfolio 2017-07-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-017-04653-1

Similar Items

Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites.
by: Bonita Durnaś, et al.
Published: (2016-01-01)

Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo
by: Bonita Durnaś, et al.
Published: (2017-07-01)

Ceragenin-Coated Non-Spherical Gold Nanoparticles as Novel Candidacidal Agents
by: Karol Skłodowski, et al.
Published: (2021-11-01)

Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
by: Niemirowicz K, et al.
Published: (2016-10-01)

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
by: Joanna Tokajuk, et al.
Published: (2022-05-01)

Ceragenin CSA-13 displays high antibacterial efficiency in a mouse model of urinary tract infection
by: Urszula Wnorowska, et al.
Published: (2022-11-01)

Use of ceragenins as a potential treatment for urinary tract infections
by: Urszula Wnorowska, et al.
Published: (2019-05-01)

Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications
by: Urszula Wnorowska, et al.
Published: (2020-01-01)

NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131
by: Chmielewska SJ, et al.
Published: (2020-09-01)

Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells
by: Piktel E, et al.
Published: (2020-06-01)

Ceragenins and Ceragenin-Based Core-Shell Nanosystems as New Antibacterial Agents against Gram-Negative Rods Causing Nosocomial Infections
by: Maciej Karasiński, et al.
Published: (2023-11-01)

Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells [Corrigendum]
by: Piktel E, et al.
Published: (2023-02-01)

Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against <it>Helicobacter pylori </it>in simulated gastric juice
by: Janmey Paul A, et al.
Published: (2009-09-01)

Sphingosine-1-Phosphate-Triggered Expression of Cathelicidin LL-37 Promotes the Growth of Human Bladder Cancer Cells
by: Tomasz Wollny, et al.
Published: (2022-07-01)

Ceragenin CSA-44 as a Means to Control the Formation of the Biofilm on the Surface of Tooth and Composite Fillings
by: Joanna Tokajuk, et al.
Published: (2022-04-01)

Bactericidal Properties of Rod-, Peanut-, and Star-Shaped Gold Nanoparticles Coated with Ceragenin CSA-131 against Multidrug-Resistant Bacterial Strains
by: Sylwia Joanna Chmielewska, et al.
Published: (2021-03-01)

Ceragenins – a new weapon to fight multidrug resistant bacterial infections
by: Urszula Surel, et al.
Published: (2014-09-01)

Peanut-Shaped Gold Nanoparticles with Shells of Ceragenin CSA-131 Display the Ability to Inhibit Ovarian Cancer Growth In Vitro and in a Tumor Xenograft Model
by: Ewelina Piktel, et al.
Published: (2021-10-01)

Salivary Cathelicidin (LL-37) in Children and Adolescents Living with HIV
by: Ana Lucia Seminario, et al.
Published: (2024-01-01)

Ceragenin-mediated disruption of Pseudomonas aeruginosa biofilms.
by: Urszula Wnorowska, et al.
Published: (2024-01-01)

Ceragenin-mediated disruption of Pseudomonas aeruginosa biofilms
by: Urszula Wnorowska, et al.
Published: (2024-01-01)

Glyoxylate Shunt and Pyruvate-to-Acetoin Shift Are Specific Stress Responses Induced by Colistin and Ceragenin CSA-13 in Enterobacter hormaechei ST89
by: Suhanya V. Prasad, et al.
Published: (2023-08-01)

Efficacy of Ceragenins in Controlling the Growth of Oral Microorganisms: Implications for Oral Hygiene Management
by: Michał Czarnowski, et al.
Published: (2024-02-01)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
by: Oriana Simonetti, et al.
Published: (2021-10-01)

Interactions of the human cathelicidin peptide LL-37 with DNA by biophysical methods.
by: Tan, Zhenwei.
Published: (2009)

Bactericidal Activity of Ceragenin in Combination with Ceftazidime, Levofloxacin, Co-Trimoxazole, and Colistin against the Opportunistic Pathogen <i>Stenotrophomonas maltophilia</i>
by: Paulina Paprocka, et al.
Published: (2022-05-01)

Extracellular DNA as an essential component and therapeutic target of microbial biofilm
by: Urszula Wnorowska, et al.
Published: (2015-07-01)

Antibacterial and Antifungal Activities of Poloxamer Micelles Containing Ceragenin CSA-131 on Ciliated Tissues
by: Marjan M. Hashemi, et al.
Published: (2018-03-01)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
by: Ibrahim H. Babikir, et al.
Published: (2018-01-01)

The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs
by: Kengo eKuroda, et al.
Published: (2015-06-01)

Significance and Diagnostic Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health
by: Zohaib Khurshid, et al.
Published: (2017-12-01)

Evaluating the Antiviral Activities of Human Cathelicidin LL-37 Peptide Against Rotavirus in Vitro
by: Zohreh Hosseini, et al.
Published: (2019-08-01)

The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus.
by: Silke M Currie, et al.
Published: (2013-01-01)

Assessment of Ceragenins in Prevention of Damage to Voice Prostheses Caused by <i>Candida</i> Biofilm Formation
by: Jakub Spałek, et al.
Published: (2021-10-01)

Toxicity of parasites and their unconventional use in medicine
by: Grzegorz Król, et al.
Published: (2019-12-01)

Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model
by: Isao Nagaoka, et al.
Published: (2020-08-01)

Retraction Note: Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans
by: Yi-jie Guo, et al.
Published: (2017-06-01)

Cathelicidin LL-37 restoring glucocorticoid function in smoking and lipopolysaccharide-induced airway inflammation in rats
by: Jian-Zhen Weng, et al.
Published: (2019-03-01)

Citrullination Alters the Antiviral and Immunomodulatory Activities of the Human Cathelicidin LL-37 During Rhinovirus Infection
by: Víctor Casanova, et al.
Published: (2020-02-01)

The human cathelicidin antimicrobial peptide LL-37 as a potential treatment for polymicrobial infected wounds.
by: Allen J Duplantier, et al.
Published: (2013-07-01)